The company, mired in too many scandals and setbacks to print, lost nearly $12 billion when all was said and done in 2024.

Staffing shortages, rising prescription drug use, and costly new therapies have driven inflation in the medical sector.

The faith-based ETF segment focuses less on generating alpha and more on adhering to religious principles and values.

Wall Street giant Goldman Sachs has emerged as the lead market maker of the $34 million Capital Group US Large Growth ETF.